Drug class
HIV-1 attachment inhibitor; prodrug of temsavir
Mechanism of action
Fostemsavir is hydrolysed to temsavir, which binds the gp120 subunit of the HIV-1 envelope glycoprotein and prevents viral attachment to the CD4 receptor, blocking an early step in viral entry.
General use cases
- Treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 for whom the current antiretroviral regimen is failing due to resistance, intolerance or safety considerations, in combination with other antiretroviral agents
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
